AAAAAA

   
Results: 1-7 |
Results: 7
Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults
Authors: Abdu, TAM Elhadd, TA Akber, M Hartland, A Neary, R Clayton, RN
Citation: Tam. Abdu et al., Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults, CLIN ENDOCR, 55(5), 2001, pp. 635-638
Coronary risk in growth hormone deficient adults: increased predicted risklargely due to lipid profile abnormalities (vol 55, pg 209, 2001)
Authors: Abdu, TAM Neary, R Elhadd, TA Akber, M Clayton, RN
Citation: Tam. Abdu et al., Coronary risk in growth hormone deficient adults: increased predicted risklargely due to lipid profile abnormalities (vol 55, pg 209, 2001), CLIN ENDOCR, 55(5), 2001, pp. 699-699
Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities
Authors: Abdu, TAM Neary, R Elhadd, TA Akber, M Clayton, RN
Citation: Tam. Abdu et al., Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities, CLIN ENDOCR, 55(2), 2001, pp. 209-216
Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency
Authors: Elhadd, TA Abdu, TA Oxtoby, J Kennedy, G McLaren, M Neary, R Belch, JJF Clayton, RN
Citation: Ta. Elhadd et al., Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency, J CLIN END, 86(9), 2001, pp. 4223-4232
Risk in cardiovascular disease - Merit of using risk reduction rather thanabsolute risk for lipid lowering drugs
Authors: Neary, R Ramachandran, S
Citation: R. Neary et S. Ramachandran, Risk in cardiovascular disease - Merit of using risk reduction rather thanabsolute risk for lipid lowering drugs, BR MED J, 321(7254), 2000, pp. 174-174
Response to Dr. Oelkers: There is enough evidence in favor of low dose ACTH test - Authors' response
Authors: Abdu, TAM Elhadd, TA Neary, R Clayton, RN
Citation: Tam. Abdu et al., Response to Dr. Oelkers: There is enough evidence in favor of low dose ACTH test - Authors' response, J CLIN END, 84(8), 1999, pp. 2973-2974
Comparison of the low dose short synacthen test (1 mu g), the conventionaldose short synacthen test (250 mu g), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease
Authors: Abdu, TAM Elhadd, TA Neary, R Clayton, RN
Citation: Tam. Abdu et al., Comparison of the low dose short synacthen test (1 mu g), the conventionaldose short synacthen test (250 mu g), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease, J CLIN END, 84(3), 1999, pp. 838-843
Risultati: 1-7 |